Harnessing the predictive power of blood-based small RNAs

Company

Hummingbird extracts deep insights into disease through the integrated analysis of both tumor and immune system derived small RNA biomarkers from whole blood.

This dual interrogation of signal from disease and the host response to disease enables a highly sensitive, robust, and AI powered platform that will revolutionize how we diagnose, treat, and manage cancer and other diseases. 

The privately held company is based in Heidelberg, Germany.

Developing novel small RNA blood tests

to improve human health

People

Our leadership

Management
Tobias Sikosek
PhD
VP Data Science
Kaja Tikk
PhD
VP Clinical Affairs
Jochen Kohlhaas
Founder & CEO
Bruno Steinkraus
PhD
CSA
Rastislav Horos
DVM PhD
CTO
Timothy Rajakumar
MD PhD
VP Medical Sciences
Board
Karoly Nikolich
Co-Founder & Board Member
Scott Gazelle
Chairman
Bernd Seibel
Vice Chairman
Tom Miller
Board Member
Michael Hadjisavas
Board Member
Hummingbird_Team.jpg

We are Hummingbird Diagnostics

Hummingbird’s dedicated and experienced team is committed to delivering results for patients.

We have developed best-in-class expertise in processing and analyzing blood-borne small RNAs, evaluating the immune system‘s response to disease with a proven track record in molecular diagnostics, clinical laboratory sciences, computational biology as well as in statistical machine learning and artificial intelligence.

a team of skilled and motivated scientists, physicians, engineers and professionals

Join Us

Our success rests upon a strong team!

We are looking for a dedicated professional in the following position:

Currently, there are no positions available.